Pharmacy Faculty Research

Title

A Randomized, Open-label, Single-dose, Four-way Crossover Pilot Study in Healthy Subjects to Assess the Pharmacokinetic Characteristics and Relative Bioavailability of Hydromorphone Following Administration of 3 Different Hydromorphone Tamper Resistant Formulations (12 mg) in the Fed and Fasted State, Compared to Palladone® (12 mg) in the Fed and Fasted State (HMP1017)

Role

Lead Pharmacist

Location

Stamford, CT

Share

COinS